Picture of Jubilant Pharmova logo

JUBLPHARMA — Jubilant Pharmova Cashflow Statement

0.000.00%
in flag iconLast trade - 00:00
HealthcareAdventurousMid CapHigh Flyer

Annual cashflow statement for Jubilant Pharmova, fiscal year end - March 31st, INR millions except per share, conversion factor applied.

2022
March 31st
2023
March 31st
2024
March 31st
2025
March 31st
2026
March 31st
Period Length:12 M12 M12 M12 M12 M
Source:ARSARSARSARSARS
Standards:
IAS
IAS
IAS
IAS
IAS
Status:FinalFinalFinalFinalFinal
Net Income/Starting Line6,3042781,7059,8066,141
Depreciation
Non-Cash Items1,9782,2883,735-1,5052,423
Discontinued Operations
Unusual Items
Equity in Net Earnings/Losses
Other Non-Cash Items
Changes in Working Capital-3,724-1,500454-1,266-700
Change in Accounts Receivable
Change in Inventories
Change in Other Assets
Change in Accounts Payable
Change in Other Liabilities
Other Operating Cash Flow
Cash from Operating Activities8,3756,6079,71310,72112,268
Capital Expenditures-6,000-8,144-8,977-11,156-14,491
Purchase of Fixed Assets
Other Investing Cash Flow Items2,1962,7002,89816,0331,891
Sale of Fixed Assets
Sale/Maturity of Investment
Change in Net Investments
Purchase of Investments
Other Investing Cash Flow
Cash from Investing Activities-3,804-5,444-6,0794,877-12,600
Financing Cash Flow Items-1,349-2,342-2,437-2,356-2,386
Other Financing Cash Flow
Total Cash Dividends Paid
Net Issuance / Retirement of Stock
Net Issuance / Retirement of Debt
Cash from Financing Activities-326-1,567-4,325-14,527949
Foreign Exchange Effects
Beginning Cash Balance
Ending Cash Balance
Net Change in Cash4,819301-5751,3191,788